Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Labetuzumab govitecan|
Labetuzumab govitecan (IMMU-130) is an antibody-drug conjugate comprised of CEACAM5 monoclonal antibody linked to the active metabolite of irinotecan (SN-38), which has potential antitumor activity (Journal of Clinical Oncology 2015 33:3_suppl, 625-625, PMID: 28817371, PMID: 30822636).
|CAS Registry Number||1469876-18-3|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Labetuzumab govitecan||Labetuzumab govitecan||1||0|